Follow-On Biologics White Paper From FDA Could Be Delayed Until Fall
This article was originally published in The Pink Sheet Daily
Executive Summary
Policy implementation is likely to require agency action before legislative initiatives, according to Reed Smith attorney Deborah Shelton.